Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2010 (2010), Article ID 381795, 8 pages
http://dx.doi.org/10.1155/2010/381795
Research Article

Refusal of Cancer-Directed Surgery Strongly Impairs Survival of Patients with Localized Hepatocellular Carcinoma

1Department of Internal Medicine, Section of Oncology-Hematology, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA
2Department of Internal Medicine, Creighton University Medical School, Omaha, NE 68131, USA

Received 15 March 2010; Revised 14 July 2010; Accepted 26 October 2010

Academic Editor: Timothy M. Pawlik

Copyright © 2010 Jue Wang and Fen Wei Wang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. E. Stuart, A. J. Anand, and R. L. Jenkins, “Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival,” Cancer, vol. 77, no. 11, pp. 2217–2222, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Makuuchi, “Surgical treatment for hepatocellular carcinoma,” in Treatments in Hepatology, V. Arroyo, J. Bosch, and J. Rodés, Eds., pp. 341–352, Masson, Barcelona, Spain, 1995. View at Google Scholar
  3. J. M. Llovet, J. Bruix, and G. J. Gores, “Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy,” Hepatology, vol. 31, no. 4, pp. 1019–1021, 2000. View at Google Scholar · View at Scopus
  4. J. Bruix, A. Castells, J. Bosch et al., “Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure,” Gastroenterology, vol. 111, no. 4, pp. 1018–1022, 1996. View at Google Scholar · View at Scopus
  5. J. M. Llovet, J. Bruix, J. Fuster et al., “Liver transplantation for small hepatocellular carcinoma: the tumor- node-metastasis classification does not have prognostic power,” Hepatology, vol. 27, no. 6, pp. 1572–1577, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. R. G. Simonetti, A. Liberati, C. Angiolini, and L. Pagliaro, “Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials,” Annals of Oncology, vol. 8, no. 2, pp. 117–136, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Lo, H. Ngan, W. K. Tso et al., “Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma,” Hepatology, vol. 35, no. 5, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. M. Llovet, M. I. Real, X. Montaña et al., “Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial,” Lancet, vol. 359, no. 9319, pp. 1734–1739, 2002. View at Publisher · View at Google Scholar · View at PubMed
  9. J. M. Llovet and J. Bruix, “Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival,” Hepatology, vol. 37, no. 2, pp. 429–442, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. J. Bruix and J. M. Llovet, “Locoregional treatments for hepatocellular carcinoma,” Bailliere's Best Practice and Research in Clinical Gastroenterology, vol. 13, no. 4, pp. 611–622, 1999. View at Publisher · View at Google Scholar
  11. S. Shiina, T. Teratani, S. Obi et al., “A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma,” Gastroenterology, vol. 129, no. 1, pp. 122–130, 2005. View at Publisher · View at Google Scholar
  12. D. Erdogan, O. R. C. Busch, D. J. Gouma, and T. M. van Gulik, “Morbidity and mortality after liver resection for benign and malignant hepatobiliary lesions,” Liver International, vol. 29, no. 2, pp. 175–180, 2009. View at Publisher · View at Google Scholar · View at PubMed
  13. S. Virani, J. S. Michaelson, M. M. Hutter et al., “Morbidity and mortality after liver resection: results of the patient safety in surgery study,” Journal of the American College of Surgeons, vol. 204, no. 6, pp. 1284–1292, 2007. View at Publisher · View at Google Scholar · View at PubMed
  14. B. Pol, P. Campan, J. Hardwigsen, G. Botti, J. Pons, and Y. P. Le Treut, “Morbidity of major hepatic resections: a 100-case prospective study,” European Journal of Surgery, vol. 165, no. 5, pp. 446–453, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Chirica, O. Scatton, P. P. Massault et al., “Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?” Archives of Surgery, vol. 143, no. 6, pp. 538–543, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. T. Poon, S. T. Fan, C. M. Lo et al., “Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database,” Annals of Surgery, vol. 240, no. 4, pp. 698–710, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Nagasue, H. Kohno, Y. C. Chang et al., “Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years,” Annals of Surgery, vol. 217, no. 4, pp. 375–384, 1993. View at Google Scholar · View at Scopus
  18. S. T. Fan, C. M. Lo, C. L. Liu et al., “Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths,” Annals of Surgery, vol. 229, no. 3, pp. 322–330, 1999. View at Google Scholar · View at Scopus
  19. “Surveillance, Epidemiology, and End Results (SEER) Program,” Public-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2006 submission. Available at: http://www.seer.cancer.gov.
  20. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Google Scholar
  21. D. R. Cox, “Regression models and life-tables,” Journal of the Royal Statistical Society B, vol. 34, pp. 187–220, 1972. View at Google Scholar
  22. A. G. Fritz, International Classification of Diseases for Oncology: ICD-O, World Health Organization, Geneva, Switzerland, 3rd edition, 2000.
  23. J. B. O'Connell, M. A. Maggard, and C. Y. Ko, “Cancer-directed surgery for localized disease: decreased use in the elderly,” Annals of Surgical Oncology, vol. 11, no. 11, pp. 962–969, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. G. J. Chang, J. M. Skibber, B. W. Feig, and M. Rodriguez-Bigas, “Are we undertreating rectal cancer in the elderly? An epidemiologic study,” Annals of Surgery, vol. 246, no. 2, pp. 215–221, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. S. Pignata, C. Gallo, B. Daniele et al., “Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP),” Critical Reviews in Oncology/Hematology, vol. 59, no. 3, pp. 243–249, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. G. Tsukioka, S. Kakizaki, N. Sohara et al., “Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival,” World Journal of Gastroenterology, vol. 12, no. 1, pp. 48–53, 2006. View at Google Scholar · View at Scopus
  27. C. N. Yeh, W. C. Lee, L. B. Jeng, and M. F. Chen, “Hepatic resection for hepatocellular carcinoma in elderly patients,” Hepato-Gastroenterology, vol. 51, no. 55, pp. 219–223, 2004. View at Google Scholar · View at Scopus
  28. C. J. Sonnenday, J. B. Dimick, R. D. Schulick, and M. A. Choti, “Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma,” Journal of Gastrointestinal Surgery, vol. 11, no. 12, pp. 1636–1646, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. D. Sloane, H. Chen, and C. Howell, “Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival,” Journal of the National Medical Association, vol. 98, no. 12, pp. 1934–1939, 2006. View at Google Scholar · View at Scopus
  30. L. E. Harrison, T. Reichman, B. Koneru et al., “Racial discrepancies in the outcome of patients with hepatocellular carcinoma,” Archives of Surgery, vol. 139, no. 9, pp. 992–996, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. M. Llovet, J. Bustamante, A. Castells et al., “Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials,” Hepatology, vol. 29, no. 1, pp. 62–67, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. K. Okuda, T. Ohtsuki, H. Obata et al., “Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients,” Cancer, vol. 56, no. 4, pp. 918–928, 1985. View at Google Scholar
  33. H. Nathan and T. M. Pawlik, “Limitations of claims and registry data in surgical oncology research,” Annals of Surgical Oncology, vol. 15, no. 2, pp. 415–423, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus